These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33317767)

  • 21. COVID-19 related regulatory change for pharmacists - The case for its retention post the pandemic.
    Lynch M; O'Leary AC
    Res Social Adm Pharm; 2021 Jan; 17(1):1913-1919. PubMed ID: 32893134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19.
    Erku DA; Belachew SA; Abrha S; Sinnollareddy M; Thomas J; Steadman KJ; Tesfaye WH
    Res Social Adm Pharm; 2021 Jan; 17(1):1954-1963. PubMed ID: 32387230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists.
    Haines SL; DeHart RM; Flynn AA; Hess KM; Marciniak MW; Mount J; Phillips BB; Saseen JJ; Zatzkin SW
    J Am Pharm Assoc (2003); 2011; 51(2):194-202. PubMed ID: 21382810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evidence-led review of the FIP global competency framework for early career pharmacists training and development.
    Bajis D; Al-Haqan A; Mhlaba S; Bruno A; Bader L; Bates I
    Res Social Adm Pharm; 2023 Mar; 19(3):445-456. PubMed ID: 36446714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding knowledge and opportunity in pharmacy.
    Wehrli A
    Am J Health Syst Pharm; 2011 Mar; 68(5):426-32. PubMed ID: 21330685
    [No Abstract]   [Full Text] [Related]  

  • 26. Global opportunity: Pharmacists working together to improve patient care.
    Ivey MF
    Am J Health Syst Pharm; 2019 Jun; 76(12):869-872. PubMed ID: 31506702
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of pharmacist during the COVID-19 pandemic: A scoping review.
    Visacri MB; Figueiredo IV; Lima TM
    Res Social Adm Pharm; 2021 Jan; 17(1):1799-1806. PubMed ID: 33317760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community pharmacists and communication in the time of COVID-19: Applying the health belief model.
    Carico RR; Sheppard J; Thomas CB
    Res Social Adm Pharm; 2021 Jan; 17(1):1984-1987. PubMed ID: 32247680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the role of the pharmacist in global health.
    Steeb DR; Joyner PU; Thakker DR
    J Am Pharm Assoc (2003); 2014; 54(5):552-5. PubMed ID: 25216886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conceptualising production, productivity and technology in pharmacy practice: a novel framework for policy, education and research.
    Baines D; Bates I; Bader L; Hale C; Schneider P
    Hum Resour Health; 2018 Oct; 16(1):51. PubMed ID: 30285766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. U.S. Public Health Service Commissioned Corps pharmacists: making a difference in advancing the nation's health.
    Flowers L; Wick J; Figg WD; McClelland RH; Shiber M; Britton JE; Ngo DK; Borders-Hemphill V; Mead C; Zee J; Huntzinger P
    J Am Pharm Assoc (2003); 2009; 49(3):446-52. PubMed ID: 19443327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing the unexpected: considerations for new pharmacy leaders.
    Peters MJ; Hall J; Hammonds WM; Rhodes JAM; Vest TA
    Am J Health Syst Pharm; 2024 Jun; 81(12):483-487. PubMed ID: 38390912
    [No Abstract]   [Full Text] [Related]  

  • 33. Expanding opportunities through patient care: Pharmacists provide care...let me tell you about it.
    Brown L
    J Am Pharm Assoc (2003); 2015; 55(4):348-53. PubMed ID: 26161478
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacy in Israel.
    Schwartzberg E; Nathan JP; Rosen B; Marom E
    Am J Health Syst Pharm; 2018 Jan; 75(1):e57-e61. PubMed ID: 29273614
    [No Abstract]   [Full Text] [Related]  

  • 35. Perceptions of current and potential public health involvement of pharmacists in developing nations: The case of Zimbabwe.
    Mdege ND; Chevo T; Toner P
    Res Social Adm Pharm; 2016; 12(6):876-884. PubMed ID: 26703215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of COVID-19 on pharmacy transitions of care services.
    Herzik KA; Bethishou L
    Res Social Adm Pharm; 2021 Jan; 17(1):1908-1912. PubMed ID: 33162381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging telecommuting pharmacists in the post-COVID-19 world.
    Martin RD
    J Am Pharm Assoc (2003); 2020; 60(6):e113-e115. PubMed ID: 32839136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacists' involvement in and attitudes toward pharmacy practice research: A systematic review of the literature.
    Awaisu A; Alsalimy N
    Res Social Adm Pharm; 2015; 11(6):725-48. PubMed ID: 25698363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy.
    Margusino-Framiñán L; Illarro-Uranga A; Lorenzo-Lorenzo K; Monte-Boquet E; Márquez-Saavedra E; Fernández-Bargiela N; Gómez-Gómez D; Lago-Rivero N; Poveda-Andrés JL; Díaz-Acedo R; Hurtado-Bouza JL; Sánchez-Gundín J; Casanova-Martínez C; Morillo-Verdugo R
    Farm Hosp; 2020 Jun; 44(7):61-65. PubMed ID: 32533674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative analysis of pharmaceutical workforce development needs across the commonwealth.
    Bates I; Patel D; Chan AHY; Rutter V; Bader L; Meilianti S; Udoh A
    Res Social Adm Pharm; 2023 Jan; 19(1):167-179. PubMed ID: 36031527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.